In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Brought to you by

Pfizer launches hostile bid for Warner-Lambert

17 Feb 2000

Executive Summary

Shortly after Warner-Lambert announced it would merge with American Home Products, Pfizer launched a hostile bid for W-L, offering 2.5 shares of its common stock for each W-L share. Based on Pfizer's 10-day average of $39.35 the offer values Warner-Lambert at $84bn, a premium of (pr)26% to market. This is the largest hostile takeover attempt in history.
Deal Industry
  • Pharmaceuticals
    • OTC, Consumer
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Payment Includes Stock

Related Companies

UsernamePublicRestriction

Register

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By